Invention Grant
US09435809B2 Method of treating and reducing the risk of acute myelogenous leukemia
有权
治疗和降低急性骨髓性白血病风险的方法
- Patent Title: Method of treating and reducing the risk of acute myelogenous leukemia
- Patent Title (中): 治疗和降低急性骨髓性白血病风险的方法
-
Application No.: US14232801Application Date: 2012-07-13
-
Publication No.: US09435809B2Publication Date: 2016-09-06
- Inventor: Stephen D. Nimer , Lan Wang
- Applicant: Stephen D. Nimer , Lan Wang
- Applicant Address: US NY New York
- Assignee: Memorial Sloan-Kettering Cancer Center
- Current Assignee: Memorial Sloan-Kettering Cancer Center
- Current Assignee Address: US NY New York
- Agency: Choate, Hall & Stewart-LLP
- International Application: PCT/US2012/046721 WO 20120713
- International Announcement: WO2013/010101 WO 20130117
- Main IPC: C12Q1/00
- IPC: C12Q1/00 ; C12N15/01 ; G01N33/574 ; G01N33/50 ; C07K16/44 ; C12N15/113 ; C12Q1/68
Abstract:
The present invention relates to methods and compositions for treating and reducing the risk of Acute Myelogenous Leukemia (AML). In particular, the invention provides methods for identifying novel treatments for AML based on reproducible and detectable changes in AML1-ETO acetylation. The present invention further provides methods of using these treatments.
Public/Granted literature
- US20140348840A1 METHOD OF TREATING AND REDUCING THE RISK OF ACUTE MYELOGENOUS LEUKEMIA Public/Granted day:2014-11-27
Information query
